Home

Peter Svennilson

CIK 1606074 · last filed 2023-01-17

Peter Svennilson is a corporate insider who has filed 64 SEC Form 4 insider transactions across 7 companies since 2018. The most recent filing shows the insider bought $266.0K of NGM on Jan 17, 2023. Across all open-market trades the lifetime net is −$56.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $216.5M across reported positions. 47 SEC filings were submitted jointly with Tim Kutzkey.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$216.53M

Companies

7

Total Filings

64

Lifetime Open-Market Net

-$56.33M

Filer Profile

Reported Address
1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158
Related Filers
Tim Kutzkey — 47 joint filings, latest 2026-02-26
COLUMN GROUP II, LP — 42 joint filings, latest 2024-12-23
Column Group II GP, LP — 42 joint filings, latest 2024-12-23
PONOI CAPITAL, LP — 42 joint filings, latest 2024-12-23
Ponoi Management, LLC — 42 joint filings, latest 2024-12-23
Ponoi Capital II, LP — 40 joint filings, latest 2024-12-23
Ponoi II Management, LLC — 40 joint filings, latest 2024-12-23
COLUMN GROUP L P — 39 joint filings, latest 2024-04-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Director 11,203,333 $1.54 $17.25M $72.49M 36 2023-01-17
RAPT Therapeutics, Inc. (RAPT) Delisted Director 193,426 $58.01 $11.22M -$43.47M 7 2022-05-27
ORIC Director 4,616,666 $12.04 $55.58M $0 3 2021-06-17
RVMD Director 705,313 $203.77 $143.72M -$84.23M 6 2021-04-28
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Director 2,604,528 $33.99 $88.53M -$1.11M 2 2021-02-19
NRIX 10%+ Owner 686,274 $25.10 $17.23M $0 1 2020-07-29
Gritstone bio, Inc. (GRTS) Delisted Director 3,102,934 $0.03 $99.9K $0 2 2019-06-20

Recent Filings

64 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-01-17 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +53,780 $266.0K EDGAR
2022-05-27 RAPT Therapeutics, Inc. (RAPT) Delisted Buy (P) +19,000 $236.6K EDGAR
2022-05-17 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +1,625,310 $4.28M EDGAR
2021-09-14 RAPT Therapeutics, Inc. (RAPT) Delisted Mixed −9,853,830 -$12.70M EDGAR
2021-06-24 RAPT Therapeutics, Inc. (RAPT) Delisted Grant (A) — $0 EDGAR
2021-06-17 ORIC Grant (A) — $0 EDGAR
2021-04-28 RVMD Sell (S) −76,410 -$3.27M EDGAR
2021-04-12 RVMD Sell (S) −70,929 -$3.15M EDGAR
2021-04-07 RVMD Sell (S) −85,668 -$4.02M EDGAR
2021-04-02 RAPT Therapeutics, Inc. (RAPT) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 64
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.